27861652|t|Surface Modification of Porous Titanium Granules for Improving Bioactivity
27861652|a|The highly porous titanium granules are currently being used as bone substitute material and for bone tissue augmentation. However, they suffer from weak bone bonding ability. The aim of this study was to create a nanostructured surface oxide layer on irregularly shaped titanium granules to improve their bioactivity. This could be achieved using optimized electrochemical anodic oxidation (anodizing) and heat treatment processes. The anodizing process was done in an ethylene glycol -based electrolyte at an optimized condition of 60 V for 3 hours. The anodized granules were subsequently annealed at 450Â°C for 1 hour. Scanning electron microscopy (SEM), energy-dispersive x-ray spectroscopy (EDS), and x-ray diffraction (XRD) were used to characterize the surface structure and morphology of the granules. The in vitro bioactivity of the samples was evaluated by immersion of specimens in simulated body fluid (SBF) for 1, 2, and 3 weeks. The human osteoblastic sarcoma cell line, MG63, was used to evaluate cell viability on the samples using dimethylthiazol-diphenyl tetrazolium bromide (MTT) assay. The results demonstrated the formation of amorphous nanostructured titanium oxide after anodizing, which transformed to crystalline anatase and rutile phases upon heat treatment. After immersion in SBF, spherical aggregates of amorphous calcium phosphate were formed on the surface of the anodized sample, which turned into crystalline hydroxyapatite on the surface of the anodized annealed sample. No cytotoxicity was detected among the samples. It is suggested that anodic oxidation followed by heat treatment could be used as an effective surface treatment procedure to improve bioactivity of titanium granules implemented for bone tissue repair and augmentation.
27861652	0	7	Surface	T082	C0205148
27861652	8	20	Modification	T033	C3840684
27861652	24	48	Porous Titanium Granules	T122	C0005479
27861652	63	74	Bioactivity	T052	C0441655
27861652	86	110	porous titanium granules	T122	C0005479
27861652	139	163	bone substitute material	T122	C0243003
27861652	172	183	bone tissue	T024	C0391978
27861652	184	196	augmentation	T061	C1293122
27861652	224	228	weak	T080	C1762617
27861652	229	233	bone	T023	C0262950
27861652	234	241	bonding	T067	C1254366
27861652	242	249	ability	T080	C0205556
27861652	289	303	nanostructured	T082	C1254362
27861652	304	311	surface	T082	C0205148
27861652	312	323	oxide layer	T080	C1522408
27861652	327	338	irregularly	T080	C0205271
27861652	339	345	shaped	T082	C0332479
27861652	346	363	titanium granules	T122	C0005479
27861652	381	392	bioactivity	T052	C0441655
27861652	423	465	optimized electrochemical anodic oxidation	T067	C1254366
27861652	467	476	anodizing	T067	C1254366
27861652	482	506	heat treatment processes	T067	C1254366
27861652	512	529	anodizing process	T067	C1254366
27861652	545	560	ethylene glycol	T109,T131	C0015083
27861652	568	579	electrolyte	T121,T197	C0013832
27861652	586	605	optimized condition	T080	C0348080
27861652	631	648	anodized granules	T167	C3853628
27861652	667	675	annealed	T067	C1254366
27861652	697	725	Scanning electron microscopy	T059	C0026020
27861652	727	730	SEM	T059	C0026020
27861652	733	769	energy-dispersive x-ray spectroscopy	T059	C2699997
27861652	771	774	EDS	T059	C2699997
27861652	781	798	x-ray diffraction	T059	C0043301
27861652	800	803	XRD	T059	C0043301
27861652	818	830	characterize	T052	C1880022
27861652	835	842	surface	T082	C0205148
27861652	843	852	structure	T082	C0678594
27861652	857	867	morphology	T082	C0543482
27861652	875	883	granules	T167	C3853628
27861652	889	897	in vitro	T080	C1533691
27861652	898	909	bioactivity	T052	C0441655
27861652	917	924	samples	T167	C0370003
27861652	929	938	evaluated	T058	C0220825
27861652	942	951	immersion	T052	C0441655
27861652	955	964	specimens	T167	C0370003
27861652	968	988	simulated body fluid	T031	C0005889
27861652	990	993	SBF	T031	C0005889
27861652	1011	1016	weeks	T079	C0439230
27861652	1022	1058	human osteoblastic sarcoma cell line	T025	C0682523
27861652	1028	1048	osteoblastic sarcoma	T191	C1704328
27861652	1060	1064	MG63	T025	C0682523
27861652	1078	1086	evaluate	T058	C0220825
27861652	1087	1101	cell viability	T043	C0007620
27861652	1109	1116	samples	T167	C0370003
27861652	1123	1179	dimethylthiazol-diphenyl tetrazolium bromide (MTT) assay	T062	C2986858
27861652	1210	1219	formation	T169	C1522492
27861652	1223	1232	amorphous	T080	C1979848
27861652	1233	1247	nanostructured	T082	C1254362
27861652	1248	1262	titanium oxide	T121,T197	C0076733
27861652	1269	1278	anodizing	T067	C1254366
27861652	1301	1312	crystalline	T104	C0444626
27861652	1313	1320	anatase	T121,T197	C0103202
27861652	1325	1331	rutile	T121,T197	C0141060
27861652	1332	1338	phases	T079	C0205390
27861652	1344	1358	heat treatment	T067	C1254366
27861652	1366	1375	immersion	T052	C0441655
27861652	1379	1382	SBF	T031	C0005889
27861652	1384	1393	spherical	T082	C0332501
27861652	1394	1404	aggregates	T080	C0205418
27861652	1408	1417	amorphous	T080	C1979848
27861652	1418	1435	calcium phosphate	T121,T197	C0006711
27861652	1455	1462	surface	T082	C0205148
27861652	1470	1485	anodized sample	T167	C0439861
27861652	1505	1516	crystalline	T104	C0444626
27861652	1517	1531	hydroxyapatite	T197	C0020326
27861652	1539	1546	surface	T082	C0205148
27861652	1554	1578	anodized annealed sample	T167	C0439861
27861652	1580	1582	No	T033	C1513916
27861652	1583	1595	cytotoxicity	T049	C0596402
27861652	1600	1608	detected	T033	C0442726
27861652	1619	1626	samples	T167	C0370003
27861652	1649	1665	anodic oxidation	T067	C1254366
27861652	1678	1692	heat treatment	T067	C1254366
27861652	1723	1750	surface treatment procedure	T067	C1254366
27861652	1762	1773	bioactivity	T052	C0441655
27861652	1777	1794	titanium granules	T122	C0005479
27861652	1811	1822	bone tissue	T024	C0391978
27861652	1823	1829	repair	T061	C0374711
27861652	1834	1846	augmentation	T061	C1293122